ODIN is a collaboration platform where industry and academia co-create open research projects relevant for drug discovery and diagnostics. The platform was established by five different universities together with a range of Danish and interantional companies within pharma and biotech.
COMPANIES should join ODIN to:
ACADEMICS should join ODIN to:
Browse the website to find more information, or contact us to learn more.
ODIN is a collaboration platform where industry and academia co-create open research projects relevant for drug discovery and diagnostics. The platform was established by five different universities together with a range of Danish and international companies within pharma and biotech.
COMPANIES should join ODIN to:
ACADEMICS should join ODIN to:
Browse the website to find more information, or contact us to learn more.
We unite bright minds from industry and academia to jointly create need-driven clinical research projects - and pave the way for innovative new treatments and diagnostics. We fund the best project ideas through competitive funding calls. Although companies cannot receive funding, it is free of charge to join.
The platform is sponsored by the Novo Nordisk Foundation with 180 million DKK from 2024-2029.
You are welcome to contact us if you have questions or comments. Reach out to odin@au.dk or find the Secretariat's direct email addresses under contacts.
Although the platform spans five Danish universities, we're based in Aarhus. Our office is located at Aarhus University, Ny Munkegade 120, blg 1521-214.